Scrip Dividend Reference Price

RNS Number : 0525Q
CVC Credit Partners European OpsLtd
14 February 2019
 

14 February 2019

 

CVC Credit Partners European Opportunities Limited

(a closed-ended investment company incorporated in Jersey with registration number 112635)

Registered Office: IFC 1, The Esplanade, St Helier, Jersey, JE1 4BP

 

Scrip Dividend Reference Price

 

Further to the Company's announcement on 29 January 2019 declaring a dividend of £0.01375 per Sterling Share and €0.01375 per Euro Share, and the publication of the Scrip Dividend Scheme circular on 24 October 2017 (the "Circular"), the Company further announces the following Scrip Reference Prices to enable Shareholders to calculate their individual scrip dividend entitlement:

 

£1.0775 per Sterling Share; and

€1.0490 per Euro Share,

 

being the average mid-market quotation of the Euro Shares and Sterling Shares on the Daily Official List of the London Stock Exchange over five trading days following and including the relevant ex-dividend date (7 February 2019 to 13 February 2019).

 

Accordingly, a shareholder electing for the scrip dividend option rather than a cash dividend would receive approximately one new ordinary share of the corresponding class for every 79 Sterling Shares or 77 Euro Shares, respectively, registered in such shareholder's name on the Record Date.

 

Terms used in this announcement have the same meaning as in the Circular.

 

 

Enquiries:

 

BNP Paribas Securities Services S.C.A. Jersey Branch

Tel: +44 (0) 1534 709181 / 813873

 

 

 

 

CVC Credit Partners European Opportunities Limited is regulated by the Jersey Financial Services Commission

 

A copy of this announcement is and will be available, subject to certain restrictions relating to persons resident in restricted jurisdictions for inspection on the Company's web site at www.ccpeol.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVTIMTTMBIBBIL
UK 100